International Children and Families HIV Clinical Trials Network for Maternal and Adolescent Care
Official title: International Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network
Funded at University of California Los Angeles · NIH-11583801 · Data updated 2026-11-12
A network conducts high-quality HIV and TB clinical trials to improve treatments for pregnant women, infants, children, and adolescents affected by HIV in resource-limited settings.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | January 1, 2014 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $536,039 |
| NIH project number | 3UM1AI106716-14S1 |
| Project ID | NIH-11583801 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include pregnant women, infants, children, and adolescents living with HIV or at risk of infection in resource-limited settings.
✕Less likely to help
Results may not directly benefit individuals outside the study’s target populations or geographic settings.
What this research studies
This grant supports a network that runs clinical trials to find better HIV therapies and strategies for ART-free remission in young people and their mothers. It emphasizes improving care in pregnant women, infants, children, and adolescents, and building laboratory and research capacity in settings with high HIV burdens. The work includes developing durable treatments, assessing safety in vulnerable populations, and informing international guidelines. It also aims to address co-infections and co-morbidities that complicate HIV care in these groups.
Why it matters
Potential benefit: If successful, the research could lead to safer, more effective HIV treatments for mothers and children and improve global guidelines for care.
How similar studies have gone: Past IMPAACT trials have influenced drug labeling and guidelines for HIV care in young populations.
Where this research is happening
-
University of California Los Angeles
Los Angeles, United States Active
Researchers
- Principal investigator: Aldrovandi, Grace M — University of California Los Angeles
- Study coordinator: Aldrovandi, Grace M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.